Difference between revisions of "Team:Cornell/policy"

Line 34: Line 34:
 
<div class="container" style = "overflow:hidden">
 
<div class="container" style = "overflow:hidden">
 
<h1 id = "collabs">Hatchery Collaborations</h1>
 
<h1 id = "collabs">Hatchery Collaborations</h1>
<p>Flavobacterium, the bacteria causing the growth of BCWD, was first reported in the early 1920s. Since then, it has emerged in both wild and propagated stocks near the Great Lakes, which remains the largest freshwater ecosystem on earth. Fish farmers have attempted a variety of methods to combat BCWD - from with pyridylmercuric acetate in the 1950s and 1960s, which is now a banned substance, to the current method of hydrogen peroxide.</p>
 
 
 
<p>Despite these methods, flavobacterium continued to affect hatcheries in the Great Lakes. In 2006, flavobacterium was found in a sea lamprey located in Lake Ontario, demonstrating that flavobacterium, though primarily affecting salmon and trout, may be able to affect other types of fish as well. In 2010, flavobacterium was found in more than 25% of rainbow trout returning to spawn in the spring. </p>
 
 
<p>And so here we are, in 2015, where there is still no cure for BCWD. We were inspired to start fishPHARM after seeing the effects of BCWD locally. We found that fish hatcheries in the Finger Lakes region, close to where we reside, constantly deal with BCWD, and wanted to aid the fish farmers in a more personal way. </p>
 
 
 
<p>fishPHARM is unique because no iGEM team has ever shared a collaboration with local fish hatcheries. We closely worked with Bath Hatchery, Rome Hatchery, and the Cornell Biological Field Station through phone calls and visits, and used this to evolve our product. The employees at all three of these hatcheries and organizations were able to provide personal accounts of their experiences with BCWD. We first toured Bath Hatchery, and were able to gain a behind the scenes look at how fish are bred and treated. Bob Sweet, a long-time employee, spoke to us about how he has seen BCWD kill up to 1000 fish in their hatchery a day. He also detailed the various statistics that he uses to check the quality of the water that the fish reside in. We used this information to develop our Heimdall app and ensure that it would provide valuable data to everyday fish farmers.</p>
 
 
 
<p>We then contacted Rome Hatchery, which has a pathology lab and specifically researches diseases such as BCWD. From Andy Noyes, a fish pathologist at Rome, we learned that BCWD affects 10-20% of fish at 8 out of 10 fish hatcheries in the area. BCWD is also particularly a nuisance because it is a vertically transmitted disease. We also were able to better understand the process that fish farmers take to treat their fish. Typically, once fish farmers notice BCWD, they will flush hydrogen peroxide through the water. If BCWD continues to occur, they will then add antibiotics. The problems with these methods are two-fold. First, hydrogen peroxide is expensive at 55 gal of H202 FDA grade for $500, and antibiotics are double this cost. Second, bacteria can easily develop resistance to antibiotics over time, so antibiotics are not a long-term solution.</p>
 
  
  
Line 52: Line 40:
 
<div class="container" style = "overflow:hidden">
 
<div class="container" style = "overflow:hidden">
 
<h1 id = "econ">Economic Analysis</h1>
 
<h1 id = "econ">Economic Analysis</h1>
 +
<p>Oxytetracycline (branded as Terramycin) costs roughly $0.70/gram. Since the total amount of antibiotic required for a 10-day treatment is 25 g/100 lbs, treatment of a fish stock with Terramycin costs about $0.025 per dollar of fish [1]. However, Terramycin is already becoming obsolete as a treatment protocol due to the rapid formation of resistant strains [2]. While the antibiotic may appear cost effective, it cannot be relied upon as a long-term solution due to the rise of antibiotic resistance. Bacterial tolerance of chemotherapeutic agents could obligate fish farmers to use more potent antibiotics, which could have undesirable side effects on their stock. Furthermore, the evolutionary capability of Flavobacterium to overcome antibiotics suggests that reliance on such agents in the future is a questionable proposition. </p>
 +
 +
<p>The total production cost of a fishPHARM has been estimated to be roughly $2.00 per 20-pound fish. This translates to about $.14 per dollar of fish. While this may seem like a nontrivial amount, fishPHARM guarantees users a peace of mind that Terramycin simply cannot match. fishPHARM’S EcnB peptide is biodegradable as well as, and thus does not pose the same environmental and health risks that antibiotics do.</p>
 +
 +
<p>It is clear that the negative consequences of Flavobacterium psychrophilum infection are acute. As reported by the New York Department of Environmental Conservation, an epizootic of BCWD once infected 25% of lake trout raised in New York State hatchery raceways [4]. Given the inedibility of infected salmonids, the organism has the potential to reduce the financial yield of a salmon population from $7/lb to $4.90/lb in this scenario. Since roughly 2.4 million tons of salmon are produced by aquaculturists each year, even a small incidence of BCWD would have dire economic ramifications. </p>
 +
 
 
 
</div>
 
</div>

Revision as of 00:14, 14 September 2015

Cornell iGEM

shopify analytics ecommerce
tracking

Overview

fishPHARM first started as an iGEM summer project motivated, but has quickly evolved into a novel start-up company with potential for immediate application and long-term impact. We have engaged in several entrepreneurship endeavors to facilitate the growth of fishPHARM as not only a synthetic biology based project, but as a locally-based business venture capable of curing BCWD worldwide. We have also partnered with a variety of fish hatcheries and research institutes in the New York State Finger Lakes Region to help take our discoveries from the lab bench and meet the demands of a growing consumer market. Through conversations with these hatcheries, which deal with bacterial coldwater disease daily, we are able to analyze the safety implications of deploying our product in the fish farming industry and compare the economic costs of our product to current solutions. fishPHARM is designed directly with the needs of your everyday fish farmer in mind. By collaborating with our consumers in the initial stages, we aim to develop a product that is not only safe and effective, but also is practical for treating BCWD in the real-world.

Hatchery Collaborations

Economic Analysis

Oxytetracycline (branded as Terramycin) costs roughly $0.70/gram. Since the total amount of antibiotic required for a 10-day treatment is 25 g/100 lbs, treatment of a fish stock with Terramycin costs about $0.025 per dollar of fish [1]. However, Terramycin is already becoming obsolete as a treatment protocol due to the rapid formation of resistant strains [2]. While the antibiotic may appear cost effective, it cannot be relied upon as a long-term solution due to the rise of antibiotic resistance. Bacterial tolerance of chemotherapeutic agents could obligate fish farmers to use more potent antibiotics, which could have undesirable side effects on their stock. Furthermore, the evolutionary capability of Flavobacterium to overcome antibiotics suggests that reliance on such agents in the future is a questionable proposition.

The total production cost of a fishPHARM has been estimated to be roughly $2.00 per 20-pound fish. This translates to about $.14 per dollar of fish. While this may seem like a nontrivial amount, fishPHARM guarantees users a peace of mind that Terramycin simply cannot match. fishPHARM’S EcnB peptide is biodegradable as well as, and thus does not pose the same environmental and health risks that antibiotics do.

It is clear that the negative consequences of Flavobacterium psychrophilum infection are acute. As reported by the New York Department of Environmental Conservation, an epizootic of BCWD once infected 25% of lake trout raised in New York State hatchery raceways [4]. Given the inedibility of infected salmonids, the organism has the potential to reduce the financial yield of a salmon population from $7/lb to $4.90/lb in this scenario. Since roughly 2.4 million tons of salmon are produced by aquaculturists each year, even a small incidence of BCWD would have dire economic ramifications.

Environmental Impact

iGEM Collaborations